奥比努图库单抗
狼疮性肾炎
医学
肾炎
皮肤病科
内科学
免疫学
美罗华
淋巴瘤
疾病
作者
Richard Furie,Brad H. Rovin,Jay Garg,Mittermayer B. Santiago,Gustavo Aroca,Adolfina Elizabeth Zuta Santillán,Dámaris Álvarez,Claudio Sandoval,Alexander Lila,James A. Tumlin,Amit Saxena,Fedra Irazoque Palazuelos,Harini Raghu,Bongin Yoo,Iftekhar Hassan,Elsa Martins,Himanshi Sehgal,Petra Kirchner,Jorge Ross Terrés,Theodore A. Omachi
标识
DOI:10.1056/nejmoa2410965
摘要
Among adults with active lupus nephritis, obinutuzumab plus standard therapy was more efficacious than standard therapy alone in providing a complete renal response. (Funded by F. Hoffmann-La Roche; REGENCY ClinicalTrials.gov number, NCT04221477.).
科研通智能强力驱动
Strongly Powered by AbleSci AI